Your Interventional Solution for Quality Outcomes
The PVI Registry measures the prevalence, demographics, management, and outcomes of patients undergoing percutaneous treatment for peripheral vascular disease — as well as carotid artery stenting (CAS) and carotid endarterectomy. In June 2020, the ACC and Society for Vascular Surgery (SVS) announced that ACC's PVI Registry will collaborate with the SVS Vascular Quality Initiative to support and steer a single vascular registry.
The new registry collaboration will provide greater opportunities to evaluate new and emerging technologies, pharmacologic therapies, and medical and lifestyle management. It will also provide a rich source of data for academicians, the Food and Drug Administration and industry looking to answer scientific questions about patient characteristics and outcomes, as well as the use and effectiveness of different treatments.
Starting in January 2021, the new registry will be operated by SVS, creating a co-branded VQI program focused on measuring and improving the care for the growing population of patients with vascular diseases.
Please note: The existing PVI Registry will continue to operate and accept patient discharges through Dec. 31, 2020. The PVI Registry will not enroll new hospitals for 2021. The ACC data collection tool will remain open through April 15, 2021, to allow sites to complete data entry for Q4 2020 and receive a final 2020 outcomes report. Hospitals will be able to access their historical PVI Registry data through Dec. 31, 2021, allowing hospitals time to determine how they would like to store or transfer these past records and reports.
Stayed tuned for more updates and details. Questions? Contact us at firstname.lastname@example.org or 800-257-4737.